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RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES
Immunogenetics in SARS: a case-
control study
Key Messages
1. Human leukocyte antigen (HLA) 
genotypes from 102 SARS patients 
(susceptible) and 108 SARS contacts 
(resistant) were obtained.
2. Allelic frequencies of the Class I 
(HLA-A, -B, and -Cw) and Class II 
(HLA-DR and -DQ) genes from these 
genetically unrelated subjects were 
compared. 
3. A significantly higher frequency of 
DRB4*01010101 was found in the 
SARS-susceptible than SARS-resistant 
group. In contrast, significantly 
higher frequencies of HLA-B*1502 
and HLADRB3*030101 were found 
in the SARS-resistant than SARS-
susceptible group. However, none of 
these associations was significant after 
Bonferroni correction. Further, analysis 
of 10/36 genetically related families did 
not reveal any HLA alleles associated 
with SARS susceptibility or resistance. 
4. We could not confirm previous 
findings of an HLA association with 
susceptibility or resistance to SARS. 
The significance of these associations 
needs to be validated by further 
independent studies.
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Introduction
Severe acute respiratory syndrome (SARS) was first reported in Guangdong 
province, China, in November 2002. Subsequently, multiple outbreaks occurred 
globally in early 2003, affecting over 8000 individuals of whom 700 died.1,2 
This highly infectious disease was caused by a novel coronavirus (SARS-CoV).3 
The clinical course was unpredictable and marked by a high fatality rate.1 Its 
clinical severity varied from a febrile condition with mild respiratory symptoms 
and radiological evidence of lung involvement to severe respiratory distress 
with extensive lung damage and recourse to assisted ventilation.1 In addition, 
individual susceptibility to the infection by the SARS-CoV was also variable. 
In SARS families, the index patient usually had one or more close household 
contacts (sharing rooms, meals and toilet facilities) with other family members 
and could have spread the virus in the early phase of the disease. Although family 
members were exposed to the same household environments, not all of them 
contracted SARS. This suggests a differential susceptibility to infection among 
family members. The mechanism of this variation remains unclear.
 The T-cell system is a critical effector pathway for killing viruses by our 
body defences. To facilitate effective killing of the correct viral targets, human 
leukocyte antigens (HLA), as cell surface proteins, participate in selection and 
establishment of an antigen specific T-cell repertoire and in subsequent activation 
of such T cells during initiation of immune responses. Classes I (HLA-A, -B, 
and -Cw) and II (HLA-DR and -DQ) of the HLA antigens are responsible for 
CD8- and CD4-T cell responses, respectively. They are highly polymorphic and 
different alleles specify different functional significances in immune responses. 
The polymorphism in this machinery may contribute to the variations of patient 
susceptibility to immune-mediated/controlled diseases.
 We examined HLA genotypes of 90 serologically confirmed SARS patients 
and found a significant increase in HLA-B*0703 frequency and a decrease 
in HLA-DRB1*0301 frequency in the SARS patients compared to the local 
Chinese population.6 A similar study in Taiwan compared the HLA genotypes 
of 33 probable SARS patients with the normal population.5 No significant 
association was identified except when comparing a highly selected group of five 
patients admitted to the intensive care unit with non-SARS health care workers; 
the HLA-B46 allele was found associated with this small SARS patient group. 
However, association with HLA-B46 was not found in our study.
 Environmental factors such as contact history with SARS patients, 
prevention practices and personal hygiene are also important determinants for 
SARS infection. Thus, stringent defintion of close contacts is critical for further 
assignment to susceptible and resistant groups.
Methods
Study design
A case-control study was conducted from April 2005 to April 2007 in 536 SARS 
index patients and contacts recruited from the Hong Kong Department of Health 
SARS database (817 SARS patients and 936 contacts), which was established for 
contact tracing during the SARS outbreak. Verbal informed consent was obtained 
from each participant over the phone in collaboration with The University of 
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Hong Kong SARS research team. Of 433 saliva specimens 
collected, only 300 subjects including 176 from 36 
genetically related (n=90) and 36 genetically unrelated 
(n=86) families completed relationship information or 
had adequate DNA extracted for HLA typing. The SARS 
index patients were considered as cases (susceptible) 
and contacts as controls (resistant) [Fig 1]. SARS was 
serologically confirmed and defined in accordance with 
the World Health Organization criteria.1 A close contact 
was defined as a person who had cared for, lived with 
(in the same household), or came into direct contact with 
body fluids of the SARS patients within 10 days before 
hospital admission. The HLA allelic frequencies between 
these susceptible and resistant groups were compared for 
identification of positive and negative HLA risk markers by 
exclusion of all genetically related members. Genetically 
related family units within index contact pairs were also 
pulled out for family analysis with the aim to cross validate 
any positive observations.
Genetically unrelated case-control analysis
To prevent potential bias, all 90 cases and contacts from 
the 36 genetically related families were excluded. Thus, to 
identify HLA susceptible and resistant alleles, 102 SARS 
patients and 108 contacts were included for comparison of 
HLA allelic frequencies for the statistical significance of 
any association. 
Genetically related familial analysis 
Of 72 families recruited, only 36 were genetically related 
(Fig 2). The members (n=86) of the other 36 genetically 
unrelated families were husband and wife, co-inhabitants 
(boyfriends and girlfriends) or in-laws (not shown). The 
family relationship of the recruited subjects (n=90) among 
the 36 genetically related families is shown (Fig 2). Among 
these 36 related families, 10 were nuclear with both parents 
and ≥1 children (Fig 2). They were analysed statistically 
using the general family-based association test (FBAT), 
defined by U=Σ Tij (Xij-E(Xij|Si )) (1), where i indexes 
pedigree, j indexes non-founders in the pedigree, and 
summation is over all i and j; Tij is a coding function for the 
trait of interest, and Xij is a coding function for the genotype. 
The coded genotype was chosen to reflect the selected 
mode of inheritance; for example, additive, dominant 
and recessive. Under the null hypothesis, the expected 
marker score, E(Xij|Si), was computed conditionally on 
the sufficient statistic 10, which is denoted by S. Under the 
null hypothesis, Mendel’s laws determine which marker 
alleles are transmitted to the affected offspring. The FBAT 
compares the observed number of alleles that are transmitted 
with those expected in Mendelian transmissions. The 
assumption of Mendelian transmissions is all that is needed 
to ensure valid results of the FBAT approach. An excess 
of alleles of one type among the affected indicates that a 
disease-susceptibility locus for a trait of interest is linked 
and associated with the marker locus. 
Human leukocyte antigen typing 
DNA was extracted from the saliva specimens from all 
SARS patients and contacts. Sequencing based typing 
(SBT) of HLA-A, -B, -Cw, DRB and DQB1 was performed 
according to the protocols established by the International 
Histocompatibility Working Group (IHWG). Sequencing 
data were analysed using the SBTengine software (Genome 
Diagnostics, Netherlands). Dynal AllSet+ SSP kit was 
used for DQA1 typing (Invitrogen, UK). The SBT method 
based on direct sequencing of the specific HLA locus after 
PCR-amplification has been established as one of the 
most reliable and sensitive HLA genotyping techniques. 
Locus-specific PCR amplification was first performed with 
primer sets as suggested by IHWG, using Taq polymerase 
(Promega) on 9700 thermal cycler (Applied Biosystems). 
Specific PCR products were excised from gels after 
electrophoresis and purified by gel DNA extraction kit 
(Qiagen). Sequencing reactions were then performed using 
BigDye 3.1 reagent (Applied Biosystems) and resolved 
on a 3130 sequencer (Applied Biosystems). Finally, the 
sequencing data were analysed by sequence alignment and 
database matching using the SBTengine software (Genome 
Diagnostics).
Results
Comparison between case (susceptible) and control 
(resistant) groups
A total of 102 SARS patients and 108 contact non-SARS 
subjects were included. The SARS group consisted of 64 
males and 38 females aged 13 to 88 (mean, 42) years. The 
contact non-SARS group consisted of 62 males and 46 
females, with age information unavailable. We compared 
the HLA frequencies between the two groups. A significantly 
higher frequency of DRB4*01010101 was found in the 
SARS than contact group (50.98% vs 30.56%, p=0.0031, 
Pc=0.093, odds ratio [OR]=2.364, 95% confidence 
interval [CI]=1.344 to 4.156), whereas significantly higher 
frequencies of HLA-B*1502 (25.93% vs 9.80%, p=0.0037, 
Pc=0.2035, OR=0.3106, 95% CI=0.1421 to 0.6788) and 
HLA-DRB3*030101 (27.78% vs 14.71%, p=0.0282, 
Pc=0.846, OR=0.4483, 95% CI=0.2246 to 0.8948) were 
observed in the contact than SARS group (Table 1). 
However, none of these associations was significant after 
the Bonferroni correction. In addition, in contrast to our 
Fig 1. SARS families: human leukocyte antigen markers for 
differential susceptibilities with similar exposures
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Fig 2. Summary of the pedigrees of the 36 genetically related families
Black boxes/circles indicate SARS index patients, whereas open boxes/circles denote resistant contacts
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previous observations, no HLA-B*0703 was identified in 
either the SARS or contact group, and HLA-DRB1*0301 
was observed in equal frequency in both groups. 
 
Analysis of genetically related family units
Ten nuclear families from the 36 genetically related 
families were analysed using the general FBAT. From 
this calculation, 12 HLA alleles with significant threshold 
frequency were further analysed but none was found to be 
significantly associated (Table 2). 
Discussion
Clinical outcome of viral infections is an interactive result 
of the virus and the host immunogenetic response; HLA 
is one important immunogenetic determinant that may 
attribute to the diversity of responses and outcomes. 
 Our previous exploratory HLA study had revealed 
a positive association of HLA-B*0703 and negative 
association of HLA-DRB1*0301 with SARS group. 
Coinheritance of HLA-B*0703 with HLA-B60 was found 
to confer an even higher risk for SARS.4 There were several 
limitations of the aforementioned study. First, comparison 
of the HLA genotypic frequencies was made between the 
SARS group and the normal population, which had not been 
exposed to SARS virus. Second, the normal population data 
for comparison were published in 1997 based mainly on 
a low-resolution platform including serotyping. Third, the 
sample size was relatively small. Our current study entailed 
a number of improvements. First, the control group could 
actually be viewed as SARS resistant, unlike the normal 
population, as they were exposed to the SARS virus and 
the circumstances of exposure were similar to those of 
the index SARS patients. Thus, more subtle associations 
if present could be detected. Second, a higher-resolution 
platform was employed and the associations if found would 
yield more refined information. Third, HLA-Cw was also 
typed for the first time, for potential association with this set 
of Class I genes. 
 Our study could not confirm the previous findings of 
HLA associations using an additional independent SARS 
cohort with improved design and typing methods. Thus, at 
this stage the previous findings remain not validated. The 
reason for the discrepancy may hinge on the sampling and 
the typing method. 
 Although positive and negative associations were found 
with one and two specific HLA genotypes respectively, 
their significance needs to be validated by further 
independent studies. Our current findings do not suggest a 
strong involvement of HLA with the genetic susceptibility 
to SARS, at least when based on the HLA genes that we 
studied. Negative findings were also reported in a study 
performed in China. Other HLA genes or alternative 
immunogenetic response genes may play a role in this 
aspect and deserve exploration. 
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